210 related articles for article (PubMed ID: 9396433)
21. Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome).
Eur Heart J; 1999 Nov; 20(21):1553-62. PubMed ID: 10529323
[TBL] [Abstract][Full Text] [Related]
22. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.
Serruys PW; Foley DP; Jackson G; Bonnier H; Macaya C; Vrolix M; Branzi A; Shepherd J; Suryapranata H; de Feyter PJ; Melkert R; van Es GA; Pfister PJ
Eur Heart J; 1999 Jan; 20(1):58-69. PubMed ID: 10075142
[TBL] [Abstract][Full Text] [Related]
23. Laser balloon angioplasty combined with local intracoronary heparin therapy: immediate and short-term follow-up results.
Glazier JJ; Jiang AJ; Crilly RJ; Spears JR
Am Heart J; 1997 Aug; 134(2 Pt 1):266-73. PubMed ID: 9313607
[TBL] [Abstract][Full Text] [Related]
24. Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART II).
Savage MP; Goldberg S; Bove AA; Deutsch E; Vetrovec G; Macdonald RG; Bass T; Margolis JR; Whitworth HB; Taussig A
Circulation; 1995 Dec; 92(11):3194-200. PubMed ID: 7586303
[TBL] [Abstract][Full Text] [Related]
25. Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study.
Cairns JA; Gill J; Morton B; Roberts R; Gent M; Hirsh J; Holder D; Finnie K; Marquis JF; Naqvi S; Cohen E
Circulation; 1996 Oct; 94(7):1553-60. PubMed ID: 8840843
[TBL] [Abstract][Full Text] [Related]
26. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.
Foley DP; Bonnier H; Jackson G; Macaya C; Shepherd J; Vrolix M; Serruys PW
Am J Cardiol; 1994 May; 73(14):50D-61D. PubMed ID: 8198025
[TBL] [Abstract][Full Text] [Related]
27. Restenosis after delayed coronary angioplasty of the culprit vessel in patients with a recent myocardial infarction treated by thrombolysis.
Bauters C; Khanoyan P; McFadden EP; Quandalle P; Lablanche JM; Bertrand ME
Circulation; 1995 Mar; 91(5):1410-8. PubMed ID: 7867181
[TBL] [Abstract][Full Text] [Related]
28. Intravascular ultrasound predictors of restenosis after percutaneous transcatheter coronary revascularization.
Mintz GS; Popma JJ; Pichard AD; Kent KM; Salter LF; Chuang YC; Griffin J; Leon MB
J Am Coll Cardiol; 1996 Jun; 27(7):1678-87. PubMed ID: 8636553
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty. A multicenter randomized double-blind placebo-controlled trial.
Serruys PW; Klein W; Tijssen JP; Rutsch W; Heyndrickx GR; Emanuelsson H; Ball SG; Decoster O; Schroeder E; Liberman H
Circulation; 1993 Oct; 88(4 Pt 1):1588-601. PubMed ID: 8403306
[TBL] [Abstract][Full Text] [Related]
30. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators.
Fischman DL; Leon MB; Baim DS; Schatz RA; Savage MP; Penn I; Detre K; Veltri L; Ricci D; Nobuyoshi M
N Engl J Med; 1994 Aug; 331(8):496-501. PubMed ID: 8041414
[TBL] [Abstract][Full Text] [Related]
31. Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
Maresta A; Balducelli M; Latini R; Bernardi G; Moccetti T; Sosa C; Barlera S; Varani E; Ribeiro da Silva EE; Monici Preti A; Maggioni AP;
Catheter Cardiovasc Interv; 2005 Mar; 64(3):375-82. PubMed ID: 15736248
[TBL] [Abstract][Full Text] [Related]
32. Immediate and late outcome of excimer laser and balloon coronary angioplasty: a quantitative angiographic comparison based on matched lesions.
Strikwerda S; Montauban van Swijndregt E; Foley DP; Boersma E; Umans VA; Melkert R; Serruys PW
J Am Coll Cardiol; 1995 Oct; 26(4):939-46. PubMed ID: 7560621
[TBL] [Abstract][Full Text] [Related]
33. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
Circulation; 1992 Jul; 86(1):100-10. PubMed ID: 1535568
[TBL] [Abstract][Full Text] [Related]
34. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
[TBL] [Abstract][Full Text] [Related]
35. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
[TBL] [Abstract][Full Text] [Related]
36. Long-term luminal renarrowing after successful elective coronary angioplasty of total occlusions. A quantitative angiographic analysis.
Violaris AG; Melkert R; Serruys PW
Circulation; 1995 Apr; 91(8):2140-50. PubMed ID: 7697842
[TBL] [Abstract][Full Text] [Related]
37. Short- and long-term clinical and quantitative angiographic results with the new, less shortening Wallstent for vessel reconstruction in chronic total occlusion: a quantitative angiographic study.
Ozaki Y; Violaris AG; Hamburger J; Melkert R; Foley D; Keane D; de Feyter P; Serruys PW
J Am Coll Cardiol; 1996 Aug; 28(2):354-60. PubMed ID: 8800109
[TBL] [Abstract][Full Text] [Related]
38. A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery.
Adelman AG; Cohen EA; Kimball BP; Bonan R; Ricci DR; Webb JG; Laramee L; Barbeau G; Traboulsi M; Corbett BN
N Engl J Med; 1993 Jul; 329(4):228-33. PubMed ID: 8316267
[TBL] [Abstract][Full Text] [Related]
39. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.
Tsuchikane E; Fukuhara A; Kobayashi T; Kirino M; Yamasaki K; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Awata N
Circulation; 1999 Jul; 100(1):21-6. PubMed ID: 10393676
[TBL] [Abstract][Full Text] [Related]
40. Reliability of quantitative coronary angiography of the target lesion immediately and 1 day after coronary balloon and excimer laser angioplasty.
Preisack MB; Athanasiadis A; Voelker W; Karsch KR
J Am Coll Cardiol; 1993 Mar; 21(4):876-84. PubMed ID: 8450156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
